Acoschimperoside P, 2’-acetate / PTCH1 Cancer Research Results

Aco, Acoschimperoside P, 2’-acetate: Click to Expand ⟱

Features: cardiac glycoside

Acoschimperoside P, 2′-acetate — a plant-derived cardiac glycoside (cardenolide-type glycoside) reported as a Hedgehog (Hh) pathway inhibitor and cytotoxic small molecule in human cancer cell lines. It is a natural product isolated from Vallaris glabra (leaves) and was characterized with full NMR assignments in the discovery report. Standard abbreviations are not established in the literature; it is typically referenced by its full name.

Primary mechanisms (ranked):

Hedgehog pathway inhibition via suppression of GLI-dependent transcriptional output
Downstream reduction of GLI-related target proteins (reported PTCH and BCL-2 decreases)
Cytotoxicity/antiproliferative activity in cancer cells (phenotypic outcome; upstream trigger not fully resolved)

Bioavailability / PK relevance: No human PK or clinical formulation data were identified in primary sources. As a highly oxygenated glycoside (cardiac glycoside-like), systemic exposure and oral bioavailability are uncertain and may be limited; translation would likely require dedicated PK/PD work and safety characterization typical for cardenolide-class agents.

In-vitro vs systemic exposure relevance: Reported pathway/cytotoxic effects are in vitro at micromolar-range concentrations; whether such exposures are achievable safely in vivo is unknown without PK data.

Clinical evidence status: Preclinical only (cell-based assays). No registered therapeutic clinical trials or regulatory status identified.

Acoschimperoside P, 2′-acetate is a natural glycoside with promising anticancer potential based on early-stage research that indicates possible induction of apoptosis, cell cycle arrest, and modulation of key signaling pathways (e.g., MAPK/ERK and PI3K/Akt). However, its pathways of action and overall clinical utility remain exploratory.

Strong cytotoxicity against human pancreatic and human prostate cancer.
Acoschimperoside is a naturally occurring glycoside that has gained interest due to its potential therapeutic properties, including anticancer effects. Glycosides are compounds in which a sugar molecule (glycone) is linked to a non-sugar moiety (aglycone). In the case of acoschimperoside, the specific sugar–aglycone combination contributes to its bioactivity.
• As a glycoside, acoschimperoside consists of a sugar moiety attached to a non-carbohydrate component. This structural motif is common among many plant-derived compounds that exhibit various pharmacological activities.
The sugar portion can influence the solubility, bioavailability, and even the targeting mechanism of the molecule within biological systems. The aglycone, on the other hand, frequently contributes to the molecule’s direct bioactivity, such as modulating signaling pathways involved in cell survival, apoptosis, or inflammation.
Similar glycosides have been studied for their effects on pathways like apoptosis (programmed cell death), cell cycle regulation, and inhibition of survival pathways (such as PI3K/AKT/mTOR and NF‑κB signaling).

Mechanistic pathway ranking for Acoschimperoside P, 2′-acetate

Rank	Pathway / Axis	Cancer Cells	Normal Cells	Primary Effect	Notes / Interpretation
1	Hedgehog signaling output	↓ GLI-pathway activity (model-dependent)	Unclear	Pathway inhibition	Identified as active in a Hedgehog signaling inhibition assay; broader target engagement upstream of GLI is not fully defined in primary reports.
2	GLI target gene/protein program	↓ PTCH; ↓ BCL-2 (dose-dependent)	Unclear	Downstream transcriptional program suppression	Reported decreases in GLI-related proteins including PTCH and BCL-2; interpret as reduced Hh/GLI output rather than direct BCL-2 targeting.
3	Cell viability and proliferation	↓ Viability in PANC1 and DU145 (dose-dependent)	Unclear	Cytotoxic/antiproliferative phenotype	Strong cytotoxicity reported in vitro; selectivity window vs non-malignant cells was not established in the key primary paper.
4	Na+/K+-ATPase axis	Unclear (context-dependent)	Unclear (context-dependent)	Putative class-related mechanism	Compound is described as a cardiac glycoside; many cardenolides engage Na+/K+-ATPase, but this was not directly demonstrated for this specific molecule in the primary Hedgehog-focused report.
5	Clinical Translation Constraint	Micromolar in-vitro activity; no in-vivo efficacy/PK established	Potential narrow safety margin (class concern)	Translation risk	Key constraints are absent PK, unknown therapeutic index, and typical cardiac glycoside safety liabilities; requires dedicated in-vivo PK/PD + tox before interpretation as a viable lead.

PTCH1, 12-transmembrane cell surface receptor Patched1: Click to Expand ⟱

Source: CGL-Driver

Type: TSG Gene

When not bound by Hh ligands, PTCH1 restrains the activity of Smo. The protein functions as a receptor protein for sonic hedgehog, desert hedgehog, and indian hedgehog proteins.
PTCH1 (Patched 1) is a gene that plays a crucial role in the Hedgehog signaling pathway, which is important for cell growth, differentiation, and tissue patterning during embryonic development. Mutations in the PTCH1 gene are associated with several types of cancer.

PTCH1 and PTCH2 act as tumor suppressors by maintaining control over Hedgehog signaling. Their loss—whether by mutation or reduced expression—leads to unchecked pathway activation, supporting cell proliferation and survival. Such abnormalities are associated with a more aggressive tumor phenotype and poorer clinical outcomes in cancers where the Hedgehog pathway is a driver of tumorigenesis.

Scientific Papers found: Click to Expand⟱

Aco,

Acoschimperoside P, 2'-acetate: a Hedgehog signaling inhibitory constituent from Vallaris glabra

in-vitro,

PC,

PANC1

 0.75–6uM

in-vitro,

Pca,

DU145

HH↓, PTCH1↓, Bcl-2↓, Gli1↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Cell Death ⓘ

Bcl-2↓, 1,

Proliferation, Differentiation & Cell State ⓘ

Gli1↓, 1, HH↓, 1, PTCH1↓, 1,
Total Targets: 4

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: PTCH1, 12-transmembrane cell surface receptor Patched1

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells